We are live on ! Find out more
CPIX icon

Cumberland Pharmaceuticals
CPIX

46 hedge funds and large institutions have $36.4M invested in Cumberland Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 12 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 6

6% more capital invested

Capital invested by funds: $34.2M → $36.4M (+$2.15M)

2% more funds holding

Funds holding: 45 → 46 (+1)

0% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 12

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
46
Holders Change
+1
Holders Change %
+2.22%
% of All Funds
1.23%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
7
Increased
12
Reduced
12
Closed
6
Calls
$10K
Puts
–
Net Calls
+$10K
Net Calls Change
+$10K

Top Buyers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$345K
2
Renaissance Technologies
Renaissance Technologies
New York
+$308K
3
Invesco
Invesco
Georgia
+$217K
4
TDC
Thompson Davis & Co
Virginia
+$213K
5
EGA
Eagle Global Advisors
Texas
+$156K

Top Sellers

Rank Fund Capital Flow
1
AI
Ariel Investments
Illinois
-$1.11M
2
GHA
GW Henssler & Associates
Georgia
-$693K
3
AIS
AlphaOne Investment Services
Pennsylvania
-$235K
4
GCP
GSA Capital Partners
United Kingdom
-$217K
5
Millennium Management
Millennium Management
New York
-$187K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$121K +$9.21K +1,475 +9%
RA
27
Royce & Associates
New York
$78K +$73K +11,700 New
DAM
28
Delta Asset Management
Tennessee
$73K – – –
Cambridge Investment Research Advisors
29
Cambridge Investment Research Advisors
Iowa
$67K – – –
GP
30
Grow Partners
California
$67K +$62.4K +10,000 New
BA
31
BlackRock Advisors
Delaware
$41K – – –
RFC
32
Russell Frank Company
Washington
$35K +$32.4K +5,198 New
NFA
33
Nationwide Fund Advisors
Ohio
$26K – – –
Creative Planning
34
Creative Planning
Kansas
$20K – – –
OC
35
Oakworth Capital
Alabama
$20K – – –
PNC Financial Services Group
36
PNC Financial Services Group
Pennsylvania
$20K – – –
Citigroup
37
Citigroup
New York
$13K -$2.56K -410 -17%
BIM
38
BlackRock Investment Management
Delaware
$13K – – –
Federated Hermes
39
Federated Hermes
Pennsylvania
$12K +$2.91K +466 +37%
OSAM
40
O'Shaughnessy Asset Management
Connecticut
$8K +$7.42K +1,188 New
BRWM
41
B. Riley Wealth Management
Tennessee
$6K – – –
TRCT
42
Tower Research Capital (TRC)
New York
$1K +$562 +90 +61%
GC
43
Globeflex Capital
California
$1K +$568 +91 New
Manulife (Manufacturers Life Insurance)
44
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$4 – – –
GHA
45
GW Henssler & Associates
Georgia
– -$693K -115,904 Closed
AIS
46
AlphaOne Investment Services
Pennsylvania
– -$235K -39,096 Closed
PM
47
Platinum Management
New York
– -$148K -24,800 Closed
CCM
48
Coldstream Capital Management
Washington
– -$127K -21,310 Closed
Ameriprise
49
Ameriprise
Minnesota
– -$65K -10,366 Closed
UBS Group
50
UBS Group
Switzerland
– -$6K -984 Closed
1
2
3

CPIX Hedge Fund Activity: Q1 2015 in Review

46 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q1 2015, worth a combined $36.4M — up 6.3% from $34.2M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new CPIX positions and 6 closed out — a net gain of 1 holder — while 12 added to existing stakes and 12 trimmed.

The largest buyer was Acadian Asset Management, adding an estimated $345K. The largest seller was Ariel Investments, cutting an estimated $1.11M.

  • 46 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q1 2015, up from 45 in Q4 2014.
  • Funds reported $36.4M of Cumberland Pharmaceuticals stock for Q1 2015, up 6.3% quarter-over-quarter.
  • 7 funds opened new Cumberland Pharmaceuticals positions in Q1 2015 and 6 closed out, a net change of +1 holder.
  • The largest Cumberland Pharmaceuticals buyer in Q1 2015 was Acadian Asset Management, an estimated $345K added.
  • The largest Cumberland Pharmaceuticals seller in Q1 2015 was Ariel Investments, an estimated $1.11M sold.

Based on aggregated 13F filings for Q1 2015.